Ethosuximide Oral Solution |
Zarontin Oral Solution |
Clinical Trial: Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
This study is currently recruiting patients.
Verified by National Taiwan University Hospital August 2004
|
Purpose
| Condition |
|---|
| Oral Cancer |
MedlinePlus related topics: Head and Neck Cancer
Study Type: Observational
Study Design: Screening, Longitudinal, Convenience Sample, Retrospective Study
Expected Total Enrollment: 60
Study start: August 2004; Expected completion: July 2005
Last follow-up: June 2005; Data entry closure: June 2005
Eligibility
Accepts Healthy Volunteers
Location and Contact Information
Taiwan
National Taiwan University Hospital, Taipei, 100, Taiwan; Recruiting
Chun-Pin Chiang, DMSc 886-2-23123456 Ext. 6855 cpchiang@ha.mc.ntu.edu.tw
Chun-Pin Chiang, DMSc, Principal Investigator
Chun-Pin Chiang, DMSc, Principal Investigator, National Taiwan University Hospital
More Information
Last Updated: September 9, 2005
Record first received: September 9, 2005
ClinicalTrials.gov Identifier: NCT00154973
Health Authority: Taiwan: Department of Health
ClinicalTrials.gov processed this record on 2005-09-13

Not Signed In -


